Not finding it? Sign in to also search OpenAlex live.
-
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial2023 European Journal Of Haematology article Immunology and Microbiology Complement system in diseases Open access
Alexander Röth, Satoshi Ichikawa, Yoshikazu Ito, Jin Seok Kim, Zsolt Nagy, Naoshi Obara, +13 more
20citations -
The Effect of Oral Iptacopan Monotherapy on Hematological Parameters in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Is Consistent Regardless of the Type of Prior Anti-C5 Treatment Received: A Post Hoc Analysis of 24-Week Data from the Randomized Phase III APPLY-PNH Trial
Régis Peffault de Latour, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Carlos de Castro, Samopriyo Maitra, +3 more
1citations -
Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp2026 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access
Lieke ter Steeg, Romy N. Bouwmeester, Mendy ter Avest, Fréderike J. Bemelman, Antonia H. M. Bouts, Obbo W Bredewold, +18 more
0citations -
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial2022 The Lancet Haematology article Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +12 more
74citations -
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions2021 International Journal of Laboratory Hematology article Immunology and Microbiology Complement system in diseases Open access
Gina Zini, Giuseppe d’Onofrio, Wendy N. Erber, Szu‐Hee Lee, Yutaka Nagai, Grzegorz Władysław Basak, +1 more
55citations -
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura2023 Journal of Thrombosis and Haemostasis article Immunology and Microbiology Complement system in diseases Open access
Linus Alexander Völker, Jessica Katharina Kaufeld, Gesa Balduin, Lena Merkel, Lucas Kühne, Dennis Alexander Eichenauer, +53 more
55citations -
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life2022 European Journal Of Haematology article Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Flore Sicre de Fontbrune, Pascale Burmester, Maria Piggin, Joana Matos, Halley Costantino, +7 more
38citations -
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry2023 Annals of Hematology article Immunology and Microbiology Complement system in diseases Open access
Britta Höchsmann, Régis Peffault de Latour, Alexander Röth, Timothy Devos, Christopher Jordan Patriquin, Wen‐Chien Chou, +4 more
19citations -
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy2025 Transplantation and Cellular Therapy article Immunology and Microbiology Complement system in diseases Open access
Michelle Long Schoettler, Eleni Gavriilaki, Enric Carreras, Bo-Kyoung Cho, Christopher E. Dandoy, Vincent T. Ho, +13 more
14citations -
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians2020 Journal of Clinical Medicine article Immunology and Microbiology Complement system in diseases Open access
Ilaria Mancini, Elisa Giacomini, Silvia Pontiggia, Andrea Artoni, Barbara Ferrari, Emanuela Maria Pappalardo, +31 more
10citations -
Patient-Reported Outcomes (PROs) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized COMMODORE 2 and COMMODORE 1 Trials
Jens Panse, Jaroslav Čermák, Olena Kyselova, Akihiko Gotoh, Fahri Şahin, Hubert Schrezenmeier, +3 more
4citations -
MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia2023 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases Open access
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Eros Di Bona, Morag Griffin, +27 more
2citations -
MDS-1141: APPULSE-PNH: Oral Iptacopan Monotherapy Demonstrates Clinically Meaningful Hemoglobin (Hb) Increases in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) and Hb≥10 g/dL on Anti-C5 Therapy2025 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases
Austin Gladston Kulasekararaj, Flore Sicre de Fontbrune, Anna Gayà, Ilene Ceil Weitz, David J. Kuter, David J. Araten, +16 more
2citations